Form 8-K - Current report:
SEC Accession No. 0001144204-17-020598
Filing Date
2017-04-17
Accepted
2017-04-17 09:07:57
Documents
7
Period of Report
2017-04-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v464291_8k.htm 8-K 25604
2 EXHIBIT 10.1 v464291_ex10-1.htm EX-10.1 279085
3 EXHIBIT 10.2 v464291_ex10-2.htm EX-10.2 56891
4 EXHIBIT 10.3 v464291_ex10-3.htm EX-10.3 148308
5 EXHIBIT 10.4 v464291_ex10-4.htm EX-10.4 51480
6 EXHIBIT 10.5 v464291_ex10-5.htm EX-10.5 47983
7 EXHIBIT 99.1 v464291_ex99-1.htm EX-99.1 8824
  Complete submission text file 0001144204-17-020598.txt   619437
Mailing Address 12325 EMMET STREET OMAHA NE 68164
Business Address 12325 EMMET ST OMAHA NE 68164 4027385480
TRANSGENOMIC INC (Filer) CIK: 0001043961 (see all company filings)

EIN.: 911789357 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36439 | Film No.: 17763651
SIC: 3826 Laboratory Analytical Instruments